PDA

View Full Version : Idera Pharmaceuticals Presents Data On IMO-3100 In Preclinical Lupus Model Showing Su



RSS Bot
02-25-2011, 05:11 PM
Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) announced that it is presenting data on IMO-3100, an antagonist of TLR7 and TLR9, in a preclinical model of lupus showing that treatment with IMO-3100 suppressed several key disease progression parameters...

More... (http://www.medicalnewstoday.com/articles/216663.php)